JP2014028813A5 - - Google Patents

Download PDF

Info

Publication number
JP2014028813A5
JP2014028813A5 JP2013169253A JP2013169253A JP2014028813A5 JP 2014028813 A5 JP2014028813 A5 JP 2014028813A5 JP 2013169253 A JP2013169253 A JP 2013169253A JP 2013169253 A JP2013169253 A JP 2013169253A JP 2014028813 A5 JP2014028813 A5 JP 2014028813A5
Authority
JP
Japan
Prior art keywords
gln
seq
ala
val
trp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013169253A
Other languages
English (en)
Japanese (ja)
Other versions
JP5722966B2 (ja
JP2014028813A (ja
Filing date
Publication date
Priority claimed from EP06090166A external-priority patent/EP1897885A1/en
Priority claimed from EP07090079A external-priority patent/EP1985624A3/en
Application filed filed Critical
Publication of JP2014028813A publication Critical patent/JP2014028813A/ja
Publication of JP2014028813A5 publication Critical patent/JP2014028813A5/ja
Application granted granted Critical
Publication of JP5722966B2 publication Critical patent/JP5722966B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013169253A 2006-09-08 2013-08-16 18f標識物質のための化合物と方法 Active JP5722966B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP06090166.7 2006-09-08
EP06090166A EP1897885A1 (en) 2006-09-08 2006-09-08 Compounds and methods for F labelled agents
EP07090079A EP1985624A3 (en) 2007-04-23 2007-04-23 Single step method of radiofluorination of biologically active compounds or biomolecules
EP07090079.0 2007-04-23

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2009527069A Division JP5603074B2 (ja) 2006-09-08 2007-09-07 18f標識物質のための化合物と方法

Publications (3)

Publication Number Publication Date
JP2014028813A JP2014028813A (ja) 2014-02-13
JP2014028813A5 true JP2014028813A5 (enExample) 2014-09-25
JP5722966B2 JP5722966B2 (ja) 2015-05-27

Family

ID=39031005

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009527069A Active JP5603074B2 (ja) 2006-09-08 2007-09-07 18f標識物質のための化合物と方法
JP2013169253A Active JP5722966B2 (ja) 2006-09-08 2013-08-16 18f標識物質のための化合物と方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2009527069A Active JP5603074B2 (ja) 2006-09-08 2007-09-07 18f標識物質のための化合物と方法

Country Status (20)

Country Link
US (1) US8557776B2 (enExample)
EP (5) EP2289564A3 (enExample)
JP (2) JP5603074B2 (enExample)
KR (1) KR20090058553A (enExample)
AR (1) AR062726A1 (enExample)
AU (1) AU2007294124A1 (enExample)
BR (1) BRPI0716554A2 (enExample)
CA (2) CA2662449A1 (enExample)
CL (1) CL2007002620A1 (enExample)
CO (1) CO6150196A2 (enExample)
CR (1) CR10654A (enExample)
IL (4) IL197363A0 (enExample)
MA (1) MA30780B1 (enExample)
MX (1) MX2009002492A (enExample)
NO (1) NO20091428L (enExample)
PE (1) PE20080850A1 (enExample)
RU (1) RU2009112716A (enExample)
TN (1) TN2009000063A1 (enExample)
TW (1) TW200829277A (enExample)
WO (1) WO2008028688A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2662449A1 (en) 2006-09-08 2008-03-13 Bayer Schering Pharma Aktiengesellschaft Compounds and methods for 18f labeled agents
EA200901142A1 (ru) * 2007-03-01 2010-04-30 Байер Шеринг Фарма Акциенгезельшафт 18f фторбензоильные меченые биологически активные соединения в качестве диагностических визуализирующих средств, а также бензотриазол-1-илоксибензоильные, 2,5-(диоксопирролидин-1-илокси)бензоильные и триметиламмониобензоильные предшественники
GB201013808D0 (en) 2010-08-18 2010-09-29 Ge Healthcare Ltd Peptide radiotracer compositions
WO2012094334A1 (en) * 2011-01-04 2012-07-12 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services One-step 18f labeling of biological substrates and uses of 18f labeled biological substrates
WO2012170602A1 (en) * 2011-06-09 2012-12-13 Ge Healthcare Limited Distillation device and method
HUE061402T2 (hu) * 2013-03-15 2023-06-28 Cancer Targeted Tech Llc 18F-jelölt PSMA-célzott PET képalkotó ágensek elõállításának módszerei és diagnosztikai módszerek velük
GB201314936D0 (en) 2013-08-21 2013-10-02 Ge Healthcare Ltd Radiolabelling method
GB201322456D0 (en) 2013-12-18 2014-02-05 Ge Healthcare Ltd Radiotracer compositions and methods
US11518754B2 (en) 2017-02-17 2022-12-06 Yale University Radiolabeled pharmaceuticals and methods of making and using same
AU2018300069C1 (en) 2017-07-11 2025-11-20 Synthorx, Inc. Incorporation of unnatural nucleotides and methods thereof
MX2020001332A (es) 2017-08-03 2020-09-09 Synthorx Inc Conjugados de citoquina para el tratamiento de enfermedades proliferativas e infecciosas.
JP2021522196A (ja) * 2018-04-20 2021-08-30 ザ ジェネラル ホスピタル コーポレイション 血液脳関門を越えて送達するためのアセチル化プロドラッグ
BR112021014415A2 (pt) 2019-02-06 2021-09-21 Synthorx, Inc. Conjugados de il-2 e métodos de uso dos mesmos
CN113150065B (zh) * 2021-03-11 2022-07-08 武汉英纳氏药业有限公司 一种合成肽及其应用
WO2022246118A2 (en) * 2021-05-20 2022-11-24 The Regents Of The University Of California Pet imaging tracers
WO2024204842A1 (ja) 2023-03-31 2024-10-03 日産化学株式会社 ピラゾール化合物及び有害生物防除剤

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989002897A1 (en) * 1987-09-24 1989-04-06 The Administrators Of The Tulane Educational Fund Therapeutic peptides
US5723578A (en) * 1987-09-24 1998-03-03 The Administrators Of Tulane Educational Fund Peptide analogs of bombesin
US5084555A (en) 1989-08-21 1992-01-28 The Administrators Of The Tulane Educational Fund An octapeptide bombesin analog
DE68928667T2 (de) * 1988-10-14 1998-10-01 Univ Tulane Peptide als arzneimittel
JP2846463B2 (ja) * 1989-06-02 1999-01-13 ジョージタウン・ユニバーシティー 抗ストレプトキナーゼ抗体の検出方法
US6232071B1 (en) 1990-06-11 2001-05-15 Gilead Sciences, Inc. Tenascin-C nucleic acid ligands
US5244883A (en) 1990-11-29 1993-09-14 The Administrators Of The Tulane Educational Fund Nonapeptide bombesin antagonists
TW432073B (en) 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
AU2010299A (en) 1997-12-24 1999-07-19 Vertex Pharmaceuticals Incorporated Prodrugs os aspartyl protease inhibitors
CN1110492C (zh) 1997-12-24 2003-06-04 沃泰克斯药物股份有限公司 天冬氨酰蛋白酶抑制剂的前药
WO1999033795A1 (en) 1997-12-24 1999-07-08 Vertex Pharmaceuticals Incorporated Prodrugs of aspartyl protease inhibitors
US6436989B1 (en) 1997-12-24 2002-08-20 Vertex Pharmaceuticals, Incorporated Prodrugs of aspartyl protease inhibitors
US6639076B1 (en) 1998-08-18 2003-10-28 Eli Lilly And Company Growth hormone secretagogues
ATE303988T1 (de) 1999-06-14 2005-09-15 Lilly Co Eli Inhibitoren von serin proteasen
US7115766B2 (en) 2000-11-30 2006-10-03 Indiana University Research & Technology Corp. Nucleophilic approach for preparing radiolabeled imaging agents and associated compounds
GB0115927D0 (en) * 2001-06-29 2001-08-22 Nycomed Amersham Plc Solid-phase nucleophilic fluorination
GB0206750D0 (en) 2002-03-22 2002-05-01 Amersham Plc Radiofluorination methods
EP1497316B1 (en) * 2002-04-09 2006-07-05 Eli Lilly And Company Growth hormone secretagogues
CA2493471C (en) * 2002-08-09 2013-02-12 Yamanouchi Europe B.V. Compounds binding to p-selectin
US20080063599A1 (en) 2002-11-18 2008-03-13 Jorge Setoain Quinquer Compounds Which Can Be Used To Diagnose And Monitor Diseases Associated With The Formation Of Amyloid Protein Fibrils
CA2516685A1 (en) * 2003-02-20 2004-09-02 University Of South Florida Peptidomimetic inhibitors of stat3 activity and their medical uses
GB0305704D0 (en) 2003-03-13 2003-04-16 Amersham Plc Radiofluorination methods
WO2006083424A2 (en) 2004-12-28 2006-08-10 The Trustees Of Columbia University In The City Of New York Radiolabeled compounds and uses thereof
US20100016295A1 (en) 2005-07-29 2010-01-21 Bayer Healthcare Llc Preparation and Use of Biphenyl Amino Acid Derivatives for the Treatment of Obesity
US20080029548A1 (en) 2006-05-05 2008-02-07 Ann De Wree Fabric treatment dispensing package
CA2662449A1 (en) 2006-09-08 2008-03-13 Bayer Schering Pharma Aktiengesellschaft Compounds and methods for 18f labeled agents

Similar Documents

Publication Publication Date Title
JP2014028813A5 (enExample)
JP2013173781A5 (enExample)
JP2012107057A5 (enExample)
JP2014102408A5 (enExample)
JP2011168603A5 (enExample)
JP2016512050A5 (enExample)
JP2011136981A5 (enExample)
JP2011182796A5 (enExample)
JP2013500200A5 (enExample)
JP2013532130A5 (enExample)
JP2016104015A5 (enExample)
JP2017005051A5 (enExample)
JP2013181136A5 (ja) ポリイミド前駆体組成物、ポリイミド成形体、及び画像形成装置
JP2012094862A5 (enExample)
JP2011037885A5 (enExample)
JP2015003980A5 (enExample)
JP2016200526A5 (enExample)
JP2013531183A5 (enExample)
JP2017528146A5 (enExample)
JP2015174855A5 (enExample)
JP2017019744A5 (enExample)
JP2015030781A5 (enExample)
JP2014508179A5 (enExample)
JP2012050714A5 (enExample)
JP2017533483A5 (enExample)